Page last updated: 2024-08-17

diethylnitrosamine and abt-100

diethylnitrosamine has been researched along with abt-100 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carloni, V; Pantaleo, P; Vizzutti, F1

Other Studies

1 other study(ies) available for diethylnitrosamine and abt-100

ArticleYear
Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive agent.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-01, Volume: 11, Issue:11

    Topics: Alkyl and Aryl Transferases; Animals; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Diethylnitrosamine; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; rap1 GTP-Binding Proteins; ras Proteins; Rats; Rats, Wistar

2005